Answers are grounded in this paper and cite their sources.
Familial combined hyperlipidemia is a genetically heterogeneous disorder involving multiple modifier and major genes.
Familial combined hyperlipidemia (FCHL) is a complex genetic disorder of unknown etiology. Recently, 'modifier' genes of the FCHL phenotype, such as the apolipoprotein AI-CIII-AIV gene cluster and LPL, have been identified in several populations. A 'major' gene for FCHL has been identified in a Finnish isolate which maps to a region syntenic to murine chromosome 3 where a locus for combined hyperlipidemia has been identified. We review these and other recent studies which indicate that FCHL is genetically heterogeneous.
No takes yet. Share an insight, caveat, or question.
Aouizerat et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: